Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|March 11, 2020
Immunotherapy in Malignant Pleural MesotheliomaCornedine J de Gooijer, Frank J Borm, Arnaud Scherpereel, et al.
Expert Review of Anticancer Therapy|March 25, 2017
Pembrolizumab for the treatment of non-small cell lung cancerMirte Muller, Robert D Schouten, Cornedine J De Gooijer, et al.
Translational Lung Cancer Research|November 19, 2020
Nivolumab in pre-treated advanced non-small cell lung cancer: long term follow up data from the Dutch expanded access program and routine clinical careRobert D Schouten, Lucie Egberink, Mirte Muller, et al.
Head & Neck|June 4, 2014
T3-T4 laryngeal cancer in The Netherlands Cancer Institute; 10-year results of the consistent application of an organ-preserving/-sacrificing protocolAdriana J Timmermans, Cornedine J de Gooijer, Olga Hamming-Vrieze, et al.
European Radiology Experimental|August 15, 2025
Prospective validation of an artificial intelligence assessment in a cohort of applicants seeking financial compensation for asbestosis (PROSBEST)Illaa Smesseim, Kevin B W Groot Lipman, Stefano Trebeschi, et al.
Pharmaceutical Research|March 30, 2022
Ritonavir-Boosted Exposure of Kinase Inhibitors: an Open Label, Cross-over Pharmacokinetic Proof-of-Concept Trial with ErlotinibRené J Boosman, Cornedine J de Gooijer, Stefanie L Groenland, et al.
European Radiology|December 25, 2022
Artificial intelligence-based diagnosis of asbestosis: analysis of a database with applicants for asbestosis state aidKevin B W Groot Lipman, Cornedine J de Gooijer, Thierry N Boellaard, et al.
The Lancet. Oncology|November 27, 2025
Pembrolizumab plus lenvatinib as second-line treatment in patients with pleural mesothelioma (PEMMELA): cohort 2 of a single-arm, phase 2 studyLi-Anne H Douma, Vincent van der Noort, Ferry Lalezari, et al.
The Lancet. Oncology|October 16, 2023
Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single-arm phase 2 studyLi-Anne H Douma, Ferry Lalezari, Vincent van der Noort, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 7, 2023
Impact of centralization of care for malignant peritoneal mesothelioma: A historical cohort study from the Dutch mesothelioma expert centersJob P van Kooten, Cornedine J de Gooijer, Jan H von der Thüsen, et al.
Pageof 2